Rockwell Medical to acquire Vantive's hemodialysis business
Rockwell Medical agrees to buy Vantive's hemodialysis concentrates, machines and water treatment business, with a Medolla, Italy campus, targeting $400 million to $450 million combined revenue.
Wixom, Michigan-based Rockwell Medical (Nasdaq: RMTI) has entered into an Equity and Asset Purchase Agreement with Vantive Limited to acquire Vantive's hemodialysis concentrates, HD machines including AK-98, water treatment systems, and related consumables and technical services business. The acquisition is expected to close in mid-2027.
Rockwell Medical will also acquire Vantive's one million square foot manufacturing campus in Medolla, Italy, within the Mirandola Biomedical District. The campus makes dry concentrate cartridges, HD machines, parts, consumables and water treatment systems. The company said it would become a more diversified global supplier of hemodialysis products and services, and estimates the combined business could generate annual revenue of $400 million to $450 million, subject to operational, currency and market assumptions.
Deal facts
- Target
- Vantive hemodialysis business
- Business
- Vantive's hemodialysis concentrates, HD machines, water treatment systems, consumables and technical services business, plus its Medolla, Italy manufacturing campus
- Buyer
- Rockwell Medical
- Seller
- Vantive Limited
- Deal type
- Strategic
- Advisers
- Perella Weinberg Partners LP financial adviser to Vantive
- Barclays financial adviser to Vantive
- Kirkland & Ellis LLP legal counsel to Vantive
- Aquilo Partners, L.P. financial adviser to Rockwell Medical
- Gibson Dunn & Crutcher LLP legal counsel to Rockwell Medical
- Status
- Announced
- Announced
- Tuesday, November 3, 2026
Sources
- Business WireNov 3, 2026
- CisionNov 3, 2026
- Business Wire via Yahoo FinanceNov 3, 2026
Written by Buyout Desk from the sources above. Spotted an error? Email corrections@buyoutdesk.com.